CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 77 filers reported holding CYCLERION THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,931,000 | -21.3% | 1,606,276 | 0.0% | 0.17% | -26.5% |
| Q2 2021 | $6,264,000 | +39.8% | 1,606,276 | 0.0% | 0.23% | +17.6% |
| Q1 2021 | $4,482,000 | -8.8% | 1,606,276 | 0.0% | 0.20% | -24.6% |
| Q4 2020 | $4,915,000 | -70.5% | 1,606,276 | -41.4% | 0.26% | -77.8% |
| Q3 2020 | $16,673,000 | +2.9% | 2,742,276 | 0.0% | 1.19% | -0.7% |
| Q2 2020 | $16,207,000 | +123.0% | 2,742,276 | 0.0% | 1.20% | +57.7% |
| Q1 2020 | $7,267,000 | +47.5% | 2,742,276 | +51.4% | 0.76% | +70.9% |
| Q4 2019 | $4,926,000 | -47.6% | 1,811,000 | +133.3% | 0.44% | -62.6% |
| Q3 2019 | $9,408,000 | +5.9% | 776,206 | 0.0% | 1.19% | +32.3% |
| Q2 2019 | $8,888,000 | – | 776,206 | – | 0.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Slate Path Capital LP | 7,157,601 | $6,156,000 | 0.40% |
| MFN Partners Management, LP | 3,389,215 | $2,915,000 | 0.13% |
| Diametric Capital, LP | 243,711 | $210,000 | 0.11% |
| Artal Group S.A. | 2,779,122 | $2,391,000 | 0.10% |
| Intrinsic Value Partners, LLC | 48,315 | $42,000 | 0.06% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 292,645 | $252,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 115,000 | $99,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 92,541 | $80,000 | 0.00% |
| COLONY GROUP LLC | 102,884 | $88,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 231,952 | $198,000 | 0.00% |